CRISPR-Cas adaptive immune systems are powerful and versatile tools for genome engineering. CRISPR-Casδ−1 is a recently discovered, evolutionarily distinct endonuclease that enables versatile cross-kingdom genome editing under miniature RNA-guiding. In this study, we present a comprehensive biochemical and structural characterization of CRISPR-Casδ−1. Biochemical analysis not only verifies that Casδ−1 exhibits robust double-stranded DNA cleavage activity and target-dependent trans-cleavage activity, but also explores in depth its precise cleavage sites and substrate saturation. Furthermore, we determine a 3.04 Å resolution cryo-EM structure of the Casδ−1-crRNA-dsDNA ternary complex, which reveals the molecular basis of protospacer-adjacent motif (PAM) recognition, crRNA-DNA heteroduplex assembly, and RuvC domain-mediated DNA cleavage. Collectively, our study reveals the structural basis and evolutionary insights into Casδ−1, advances the mechanistic understanding of type V CRISPR-Cas effectors, and offers opportunities for the rational design of CRISPR-Casδ−1 as a versatile genome-editing tool. Casδ−1 is a recently discovered type V CRISPR endonuclease enabling miniature RNA-guided genome editing. In this study, the authors reveal its structural basis and evolutionary insights, advancing understanding of compact CRISPR systems.
No takes yet. Share an insight, caveat, or question.
(311258) et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: